@article {334, title = {Pharmacist{\textquoteright}s Knowledge of High-risk/Alert Medications in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {December 2022}, pages = {65-71}, type = {Research Article }, chapter = {65}, abstract = {

Objectives: To explore pharmacist{\textquoteright}s knowledge of High-risk/Alert medications in Saudi Arabia. Methods: It analyzes a cross-sectional survey discussing pharmacist knowledge of High-risk/Alert medications in Saudi Arabia. The survey consisted of respondents{\textquoteright} demographic information about pharmacists, the High-risk/Alert medications assessment of basic knowledge, and The Resources used about the High risk or high-alert medications. The 5-point Likert response scale system was used with closed-ended questions. The survey was validated through the revision of expert reviewers and pilot testing. Besides, various tests of the reliability of McDonald{\textquoteright}s ω, Cronbach alpha, Gutmann{\textquoteright}s λ2, and Gutmann{\textquoteright}s λ6 been done with the study. Furthermore, the data analysis of the pharmacist{\textquoteright}s knowledge of High-risk/ Alert medications is done through the survey monkey system. Besides, the statistical package of social sciences (SPSS), Jeffery{\textquoteright}s Amazing Statistics Program (JASP), and Microsoft Excel sheet version 16. Results: A total number of 442 pharmacists responded to the questionnaire. Of them, more than one-third responded from the Central region (183 (40.40\%)), and one Quarter responded from the Western part (119 (26.92\%)), with statistically significant differences between the provinces (p=0.000). Males responded more than females (264 (59.59\%)) versus 179 (40.41\%)), with statistically significant differences between all levels (p=0.000). Most of the responders were in the age group of 24-30 years (266 (59.91\%)) and 31-35 years (78 (17.57\%)), with statistically significant differences between all age groups (p=0.000). Most of the pharmacists were staff pharmacists (323 (72.75\%)) and pharmacy supervisors (56 (12.61\%)), with statistically significant differences between all levels (p=0.000). The average score of knowledge of pharmacists about High-risk/ Alert medications was (3.71). The pharmacists familiar with prohibited abbreviations during High-risk/Alert prescribing medications obtained the highest score (4.42). The element {\textquotedblleft}heard about the concept of High-risk/Alert medications{\textquotedblright} got the second highest score (4.39), with a statistically significant difference between the responses (p\<0.000). Followed by the pharmacists familiar with look-alike sound-alike of Highrisk/ Alert medications (4.30) and know the narcotics and controlled medications (4.27) ), with a statistically significant difference between the responses (p\<0.000). The most used resources for High-risk/Alert or high-alert medication information were Drug information resources (Lexi comp-drug information, Micromedex, Epocrates etc. 345 (78.05\%), and Scientific literature 222 (50.23\%). They were followed by Health practitioners 206 (46.61\%) SFDA website 157 (35.52\%). Conclusion: The pharmacist{\textquoteright}s knowledge of High-risk/Alert medications is adequate in Saudi Arabia. However, an expanded basic and advanced understanding of High-risk/Alert areas is needed to improve pharmacy performance, patient safety, and quality of life in Saudi Arabia.

}, keywords = {Alert, Drugs., High-risk, Knowledge, Medications, Pharmacist}, doi = {10.5530/ijpcs.2022.11.13}, author = {Yousef Ahmed Alomi and Nouf Saad Al-Saban and Maha Hussein Almadany and Randa Jaroudi and Faisal Safouq Alanazi and Musleh Samil Reshidi} } @article {337, title = {Practice of High-Risk/Alert Medications by Pharmacists in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {December 2022}, pages = {92-103}, type = {Research Article }, chapter = {92}, abstract = {

Objectives: To illustrate the pharmacist practice of High-Risk/Alertmedications in Saudi Arabia. Methods: It analyzes a cross-sectional survey that discussed the Pharmacist practice of High-Risk/Alert medications in Saudi Arabia. The survey consisted of respondents{\textquoteright} demographic information about pharmacists and practices, Basic and advanced High-Risk/Alertmedications practice implementation, the High- Risk/Alertdrugs implemented in the following medication stages, and medications considered high alert or high risk at your institution. The 5-point Likert response scale system was used with closed-ended questions. The survey was validated through the revision of expert reviewers and pilot testing. Besides, various tests of reliability, McDonald{\textquoteright}s ω, Cronbach alpha, Gutmann{\textquoteright}s λ2, and Gutmann{\textquoteright}s λ6 been done with the study. Furthermore, the data analysis of the Pharmacist practice of High-Risk/ Alert medications is done through the survey monkey system. Besides, the statistical package of social sciences (SPSS), Jeffery{\textquoteright}s Amazing Statistics Program (JASP), and Microsoft Excel sheet version 16. Results: A total number of 442 pharmacists responded to the questionnaire. Of them, more than one-third responded from the Central region (183 (40.40\%)), and one Quarter responded from the Western part (119 (26.92\%)), with statistically significant differences between the provinces (p=0.000). Males responded more than females (264 (59.59\%)) versus 179 (40.41\%)), with statistically significant differences between all levels (p=0.000). Most of the responders were in the age group of 24-30 years (266 (59.91\%)) and 31-35 years (78 (17.57\%)), with statistically significant differences between all age groups (p=0.000). Most of the pharmacists were staff pharmacists (323 (72.75\%)) and pharmacy supervisors (56 (12.61\%)), with statistically significant differences between all levels (p=0.000). The average score of the practice of pharmacists{\textquoteright} basic of High-Risk/Alertmedications was (3.81). The element {\textquotedblleft}The risk medications is a part of medications safety vision{\textquotedblright} obtained the highest score (4.18), and the element {\textquotedblleft}Policy and procedure of High-Risk/ Alertmedications {\textquotedblleft} was (4.18). Followed the {\textquotedblleft}The High-Risk/Alertmedications is a part of medications safety Mission{\textquotedblright} (4.12). The average advanced High-Risk/Alertmedications practice implementation score was (3.62). The element {\textquotedblleft}The pharmacist share in medications safety committee for High-Risk/Alertmedications discussion{\textquotedblright} (4.12) and the element {\textquotedblleft}There is documentation of potential impact and outcomes with High- Risk/Alertmedications {\textquotedblleft} was (3.85). The average score of High-Risk/Alertmedications implemented in the medications stages was (3.99). The dispensing stage obtained the highest score (4.21), and the administration stage (4.12). Most drugs considered high alert or high risk at the institutions were antithrombotic agents 332 (77.39\%) and adrenergic agonists 330 (76.92\%). They were followed by insulin 285 (66.43\%) and inotropic medications 284 (65.97\%). Conclusion: The pharmacist{\textquoteright}s practice of High- Risk/Alertmedication is sufficient in Saudi Arabia. However, more expanded training in anesthesia and operation rooms has been successfully implemented. That leads to many preventive drug-related problems and avoids unnecessary economic burdens on the healthcare system.

}, keywords = {Alert, Drugs., High-risk, Medications, Pharmacist, Practice}, doi = {10.5530/ijpcs.2022.11.16}, author = {Yousef Ahmed Alomi and Nouf Saad Al-Saban and Randa Jaroudi and Hussain Mohammed Ibrahim Aareji and Faisal Safouq Alanazi and Maha Hussein Almadany} }